Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,431 GBX | +0.84% | -0.51% | +17.06% |
Jun. 27 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
Jun. 26 | European Equities Close Lower in Wednesday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.06% | 242B | |
+56.17% | 819B | |
-6.86% | 351B | |
+19.29% | 329B | |
+9.22% | 298B | |
+2.21% | 225B | |
+13.30% | 217B | |
+9.13% | 168B | |
-3.13% | 158B | |
+0.18% | 120B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Barclays maintains a Buy rating